Samsrita Labs (BOM:539267) Short Ratio

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:539267 Samsrita Labs Ltd BOM:539267
25 GF Score
Price ₹11.60
! 3 Warning Signs
View Full Analysis

What is Samsrita Labs Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

BOM:539267
25GF Score
Samsrita Labs Ltd BOM:539267
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Samsrita Labs Business Description

Address Suryateja Apartments, 6-3-354/13/B2, Flat No. B2, Hindinagar, Punjagutta, Hyderabad, TG, IND, 500082
Samsrita Labs Ltd is an India-based healthcare company engaged in stem cell research and therapy, new drug discovery, diagnostics and bio lab services, pharmacy operations, and outpatient consultancy through its ORIGIN HOSPITALS network. The company operates in a single reportable healthcare services segment that spans hospitals, diagnostics, pharmaceuticals, and biotechnology, serving patients and healthcare providers across India. It also pursues biotechnology research and development activities. In addition, Samsrita Labs has been expanding into the pet animal care and wellness sector, focusing on AI-enabled veterinary diagnostics, telehealth, predictive health monitoring, nutrition, and related pet care solutions. Revenue is generated primarily through healthcare services, diagnostics, pharmacy sales, and biotechnology-related activities, with the company positioned as a diversified player across human and veterinary health markets in India.
25GF Score

Get the complete analysis for BOM:539267

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹11.60
Price